LGI1-antibody encephalitis: how to approach this highly treatable dementia mimic in memory and mental health services.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38699852.
- Also identified by DOI 10.1192/bjp.2024.72 and PMC identifier 7615977.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Leucine-rich glioma-inactivated 1-antibody-encephalitis is a treatable and potentially reversible cause of cognitive and psychiatric presentations, and may mimic cognitive decline, rapidly progressive dementia and complex psychosis in older patients. This aetiology is of immediate relevance given the alternative treatment pathway required, compared with other conditions presenting with cognitive deficits.
Medical subject headings
- Dementia
- Autoantibodies